NCT06684535

Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain

Role of Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain: A Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study aims to evaluate the role of dexmedetomidine as an adjuvant in external oblique intercostal plane block for post-thoracotomy pain.

Detailed description

External oblique intercostal plane block (EOIPB) is a novel block that has been described as an important modification of the fascial plane blocks that can consistently involve the upper lateral abdominal walls. Dexmedetomidine is a selective alpha 2- adrenoceptor agonist possessing sedative, anxiolytic, and analgesic properties without the development of respiratory depression.

Conditions

• Dexmedetomidine
• Adjuvant
• External Oblique Intercostal Plane Block
• Thoracotomy
• Pain

Interventions

Type	Name	Description
DRUG	Dexmedetomidine	Patients will receive 29 ml bupivacaine 0.25% + 1 ml dexmedetomidine 0.5 μg/kg.
DRUG	Saline	Patients will receive 29 ml bupivacaine 0.25% + 1 ml saline.

Timeline

• Start date: 2024-11-14
• Primary completion: 2025-07-07
• Completion: 2025-07-07
• First posted: 2024-11-12
• Last updated: 2025-07-24

Locations

1 site across 1 country: Egypt